Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

In a 3D model of breast morphogenesis, CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1) plays an essential role in lumen formation in a subline of the nonmalignant human breast cell line (MCF10A). We show that mammary carcinoma cells (MCF7), which do not express CEACAM1 or form lumena when grown in Matrigel, are restored to a normal morphogenic program when transfected with CEACAM1-4S, the short cytoplasmic isoform of CEACAM1 that predominates in breast epithelia. During the time course of lumen formation, CEACAM1-4S was found initially between the cells, and in mature acini, it was found exclusively in an apical location, identical to its expression pattern in normal breast. Lumena were formed by apoptosis as opposed to necrosis of the central cells within the alveolar structures, and apoptotic cells within the lumena expressed CEACAM1-4S. Dying cells exhibited classical hallmarks of apoptosis, including nuclear condensation, membrane blebbing, caspase activation, and DNA laddering. Apoptosis was mediated by Bax translocation to the mitochondria and release of cytochrome c into the cytoplasm, and was partially inhibited by culturing cells with caspase inhibitors. The dynamic changes in CEACAM1 expression during morphogenesis, together with studies implicating extracellular matrix and integrin signaling, suggest that a morphogenic program integrates cell–cell and cell–extracellular matrix signaling to produce the lumena in mammary glands. This report reveals a function of CEACAM1-4S relevant to cellular physiology that distinguishes it from its related long cytoplasmic domain isoform.

Bibliography

Kirshner, J., Chen, C.-J., Liu, P., Huang, J., & Shively, J. E. (2003). CEACAM1-4S, a cell–cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proceedings of the National Academy of Sciences, 100(2), 521–526.

Authors 5
  1. Julia Kirshner (first)
  2. Charng-Jui Chen (additional)
  3. Pingfang Liu (additional)
  4. Jie Huang (additional)
  5. John E. Shively (additional)
References 40 Referenced 146
  1. 10.1016/0161-5890(79)90063-4
  2. 10.1016/S0955-0674(97)80114-7
  3. 10.1073/pnas.85.18.6959
  4. 10.1083/jcb.108.2.267
  5. 10.1128/mcb.13.2.1273-1282.1993
  6. P Nollau, H Scheller, M Kona-Horstmann, S Rohde, F Hagenmuller, C Wagener, M Neumaier Cancer Res 57, 2354–2357 (1997). / Cancer Res by Nollau P (1997)
  7. 10.1177/002215549704500705
  8. J Huang, J F Simpson, C Glackin, L Riethorf, C Wagener, J E Shively Anticancer Res 18, 3203–3212 (1998). / Anticancer Res by Huang J (1998)
  9. 10.1073/pnas.90.22.10744
  10. J T Hsieh, W Luo, W Song, Y Wang, D I Kleinerman, N T Van, S H Lin Cancer Res 55, 190–197 (1995). / Cancer Res by Hsieh J T (1995)
  11. S H Lin, Y S Pu Semin Oncol 26, 227–233 (1999). / Semin Oncol by Lin S H (1999)
  12. 10.1006/bbrc.1999.1443
  13. 10.1097/00005392-199909010-00085
  14. 10.1242/jcs.112.23.4193
  15. 10.1002/(SICI)1097-4652(199704)171:1<11::AID-JCP2>3.0.CO;2-K
  16. 10.1091/mbc.10.9.2817
  17. 10.1073/pnas.89.19.9064
  18. 10.1073/pnas.95.25.14821
  19. 10.1083/jcb.137.1.231
  20. 10.1016/S0959-8049(00)00062-9
  21. 10.1016/0304-3835(91)90093-W
  22. 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J
  23. 10.1083/jcb.138.6.1379
  24. 10.1038/sj.cdd.4400404
  25. 10.1074/jbc.273.16.9357
  26. M Rojas, A Fuks, C P Stanners Cell Growth Differ 1, 527–533 (1990). / Cell Growth Differ by Rojas M (1990)
  27. 10.1016/S0021-9258(18)52436-4
  28. 10.1016/0006-291X(92)90828-9
  29. 10.1038/sj.onc.1202935
  30. T Kunath, C Ordonez-Garcia, C Turbide, N Beauchemin Oncogene 11, 2375–2382 (1995). / Oncogene by Kunath T (1995)
  31. 10.1016/0092-8674(95)90169-8
  32. 10.1074/jbc.M109110200
  33. 10.1016/S0014-5793(98)00222-1
  34. 10.1182/blood.V84.1.211.211
  35. L Frangsmyr, V Baranov, F Prall, M M Yeung, C Wagener, S Hammarstrom Cancer Res 55, 2963–2967 (1995). / Cancer Res by Frangsmyr L (1995)
  36. 10.1083/jcb.96.4.1168
  37. H Sun, S A Santoro, M M Zutter Cancer Res 58, 2224–2233 (1998). / Cancer Res by Sun H (1998)
  38. 10.1126/science.7531366
  39. 10.1016/S0002-9440(10)61725-7
  40. 10.1038/ncb0901-785
Dates
Type When
Created 22 years, 7 months ago (Jan. 21, 2003, 5:51 p.m.)
Deposited 3 years, 4 months ago (April 13, 2022, 9:07 a.m.)
Indexed 3 months, 1 week ago (May 19, 2025, 8:30 a.m.)
Issued 22 years, 7 months ago (Jan. 9, 2003)
Published 22 years, 7 months ago (Jan. 9, 2003)
Published Online 22 years, 7 months ago (Jan. 9, 2003)
Published Print 22 years, 7 months ago (Jan. 21, 2003)
Funders 0

None

@article{Kirshner_2003, title={CEACAM1-4S, a cell–cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture}, volume={100}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.232711199}, DOI={10.1073/pnas.232711199}, number={2}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Kirshner, Julia and Chen, Charng-Jui and Liu, Pingfang and Huang, Jie and Shively, John E.}, year={2003}, month=jan, pages={521–526} }